Dynamic Technology Lab’s Outset Medical OM Stock Holding History

Dynamic Technology Lab’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,988	Closed	-$161K	–	1315
2023 Q4	$161K	Buy	+1,988	New	+$162K	0.02%	907
2023 Q2	–	Sell	-892	Closed	-$246K	–	1305
2023 Q1	$246K	Buy	+892	New	+$327K	0.02%	851
2021 Q4	–	Sell	-317	Closed	-$235K	–	1389
2021 Q3	$235K	Buy	+317	New	+$216K	0.03%	850

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Dynamic Technology Lab's OM Position: Q1 2024 in Review

Dynamic Technology Lab sold out of Outset Medical (OM) in Q1 2024, closing a stake of 1,988 shares — an estimated $161K sold.

Dynamic Technology Lab first reported a position in OM in Q3 2021 and held it in 3 quarters. The position peaked at $246K in Q1 2023. 114 funds tracked by Wall St. Rank hold OM as of Q1 2024.

Dynamic Technology Lab reported no remaining Outset Medical position as of Q1 2024 after selling out during the quarter.
Dynamic Technology Lab sold 1,988 Outset Medical shares in Q1 2024, an estimated $161K.
Dynamic Technology Lab first reported a position in Outset Medical in Q3 2021 and held it in 3 quarters.
Dynamic Technology Lab's Outset Medical position peaked at $246K in Q1 2023.
114 funds tracked by Wall St. Rank held Outset Medical as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.